Karan S. Takhar SEC EDGAR Filings (CIK 0001807398)

SEC EDGAR filings, ownership reports, and insider transactions for Karan S. Takhar.

Business address
C/O Zentalis Pharmaceuticals,Inc., 530 Seventh Avenue, Suite 2201, New York, NY, 10018
Get insider transactions for this reporting owner
Karan S. Takhar has filed 2 SEC EDGAR filings since 03 Apr 2020

Latest Filings

Recent SEC filings for Karan S. Takhar including 3.

Form type Document Filing Description Filing date Reporting date File number(s)
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 28 Oct 2021 28 Oct 2021 001-40971
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Apr 2020 03 Apr 2020 001-39263

About this filer

Karan S. Takhar files with the SEC under CIK 0001807398. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages